Lipo-Dox
AmBiL
Doxisome
ProFlow
ProDex
Lipotecan
 
  AmBiL
 
 
Generic form of AmBisome®. As a liposomal formulation of Amphotericin B, AmBiL® has effectively reduced toxicities and allowed patients to receive higher and more effective doses.
 
     
 
  Indications   Systemic fungal infection  
 
Advantages
 
AmBiL® is capable of achieving the same safety level as AmBisome® (which is superior than those of other amphotericin B formulations), making AmBiL® the first generic form of AmBisome®
 
 
     
  Development Status  
 
Bioequivalence ANDA On Market